TipRanks
Advertisement
Advertisement
Apogee Shareholders Approve AbbVie Acquisition and Leadership Transition
PremiumCompany AnnouncementsApogee Shareholders Approve AbbVie Acquisition and Leadership Transition
1M ago
Apogee Therapeutics’ Merger Faces Significant Execution Risks, Potential $381 Million Termination Fee and Stock Price Pressure
Premium
Company Announcements
Apogee Therapeutics’ Merger Faces Significant Execution Risks, Potential $381 Million Termination Fee and Stock Price Pressure
1M ago
3 Best ETFs With 50%+ Upside to Buy in August 2026, According to Analysts
Premium
Market News
3 Best ETFs With 50%+ Upside to Buy in August 2026, According to Analysts
1M ago
Apogee Therapeutics price target raised to $135 from $97 at RBC Capital
PremiumThe FlyApogee Therapeutics price target raised to $135 from $97 at RBC Capital
3M ago
Apogee Therapeutics moved to No Rating at BofA
Premium
The Fly
Apogee Therapeutics moved to No Rating at BofA
3M ago
Apogee Therapeutics downgraded to Neutral from Buy at Citi
Premium
The Fly
Apogee Therapeutics downgraded to Neutral from Buy at Citi
3M ago
Apogee Therapeutics rises 46.8%
PremiumThe FlyApogee Therapeutics rises 46.8%
3M ago
Apogee Therapeutics downgraded to Hold from Buy at Craig-Hallum
Premium
The Fly
Apogee Therapeutics downgraded to Hold from Buy at Craig-Hallum
3M ago
Apogee Therapeutics downgraded to Neutral from Outperform at Wedbush
Premium
The Fly
Apogee Therapeutics downgraded to Neutral from Outperform at Wedbush
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100